Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR11076] to CXCL11 - BSA and Azide free
- Suitable for: WB
- Reacts with: Human
Product nameAnti-CXCL11 antibody [EPR11076] - BSA and Azide free
See all CXCL11 primary antibodies
DescriptionRabbit monoclonal [EPR11076] to CXCL11 - BSA and Azide free
Tested applicationsSuitable for: WBmore details
Unsuitable for: ICC/IF or IHC-P
Species reactivityReacts with: Human
This product was produced with the following immunogens:
Synthetic peptide within Human CXCL11 aa 1 to the C-terminus. The exact sequence is proprietary.
Database link: O14625
Synthetic peptide within Human CXCL11 aa 1 to the C-terminus (Cysteine residue). The exact sequence is proprietary.
Database link: O14625
- WB: Human fetal spleen and THP1 lysates.
Ab240234 is the carrier-free version of ab181035. This format is designed for use in antibody labeling, including fluorochromes, metal isotopes, oligonucleotides, enzymes.
Our carrier-free formats are supplied in a buffer free of BSA, sodium azide and glycerol for higher conjugation efficiency.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with <1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
ab240234 is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm.
Maxpar® is a trademark of Fluidigm Canada Inc.
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
We are constantly working hard to ensure we provide our customers with best in class antibodies. As a result of this work we are pleased to now offer this antibody in purified format. We are in the process of updating our datasheets. The purified format is designated 'PUR' on our product labels. If you have any questions regarding this update, please contact our Scientific Support team.
Storage instructionsShipped at 4°C. Store at +4°C. Do Not Freeze.
Storage bufferpH: 7.2
Concentration information loading...
PurityProtein A purified
Our Abpromise guarantee covers the use of ab240234 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||Use at an assay dependent concentration. Predicted molecular weight: 10 kDa.|
FunctionChemotactic for interleukin-activated T-cells but not unstimulated T-cells, neutrophils or monocytes. Induces calcium release in activated T-cells. Binds to CXCR3. May play an important role in CNS diseases which involve T-cell recruitment. May play a role in skin immune responses.
Tissue specificityHigh levels in peripheral blood leukocytes, pancreas and liver astrocytes. Moderate levels in thymus, spleen and lung. Low levels in placenta, prostate and small intestine. Also found in epidermal basal layer keratinocytes in skin disorders.
Sequence similaritiesBelongs to the intercrine alpha (chemokine CxC) family.
- Information by UniProt
- b R1 antibody
- b-R1 antibody
- Beta-R1 antibody
All lanes : Anti-CXCL11 antibody [EPR11076] (ab181035) at 1/1000 dilution (Unpurified)
Lane 1 : Human spleen lysate
Lane 2 : THP-1 (human monocytic leukemia cell line) cell lysate
Lysates/proteins at 10 µg per lane.
All lanes : Standard HRP-labeled goat anti-rabbit at 1/2000 dilution
Predicted band size: 10 kDa
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab181035).
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
ab240234 has not yet been referenced specifically in any publications.